Literature DB >> 24981856

Consumption of antidepressants in Italy: recent trends and their significance for public health.

Maria Rosaria Gualano, Fabrizio Bert, Alice Mannocci, Giuseppe La Torre, Patrizia Zeppegno, Roberta Siliquini.   

Abstract

OBJECTIVES: The study assessed the consumption of antidepressants in Italy between 2000 and 2011 and identified trends in use.
METHODS: Data on use of antidepressant drugs between 2000 and 2011 were collected from the Italian Medicines Agency database. Data were expressed as the daily defined dose (DDD) per 1,000 inhabitants. Trends in drug consumption were ascertained by logarithmic transformation of incidence rates by using the formula ln(y)=b × x, where y is the incidence rate, b is the regression coefficient, and x represents the calendar years. Time trends were expressed as expected annual percentage change (EAPC). A significance level of .05 was chosen.
RESULTS: Antidepressant consumption increased drastically between 2000 and 2011, from 8.18 to 36.12 DDD per 1,000 inhabitants per day. A single joinpoint (time point with a significant trend change) occurred in 2002 (EAPC=56.4%, 2000-2002, and 6.2%, 2002-2011). The trend analysis stratified by type of drug showed a huge increase in consumption of selective serotonin reuptake inhibitors and other antidepressants and a decrease in consumption of tricyclic antidepressants.
CONCLUSIONS: Mental disorders are less stigmatized now than in the past. In Italy and elsewhere, antidepressant use is growing, and it would be important to monitor this trend, especially considering the possible effects of the current economic crisis on mental health. In this scenario, the role of public health in mental health promotion has become fundamental.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24981856     DOI: 10.1176/appi.ps.201300510

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

1.  Chronic Escitalopram Treatment Does Not Alter the Effects of Neonatal Stress on Hippocampal BDNF Levels, 5-HT1A Expression and Emotional Behaviour of Male and Female Adolescent Rats.

Authors:  Lorena Henn; Natália C Zanta; Carlos Eduardo N Girardi; Deborah Suchecki
Journal:  Mol Neurobiol       Date:  2020-10-15       Impact factor: 5.590

2.  Selective Serotonin Reuptake Inhibitor Promotes Bone-Tendon Interface Healing in a Rotator Cuff Tear Rat Model.

Authors:  Jong Pil Yoon; Jee Wook Yoon; Hun-Min Kim; Joo Han Oh
Journal:  Tissue Eng Regen Med       Date:  2022-04-19       Impact factor: 4.451

3.  Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study.

Authors:  Luca Degli Esposti; Diego Sangiorgi; Claudio Mencacci; Edoardo Spina; Carlotta Pasina; Marianna Alacqua; Flore la Tour
Journal:  BMC Psychiatry       Date:  2014-10-14       Impact factor: 3.630

Review 4.  Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Janus Christian Jakobsen; Kiran Kumar Katakam; Anne Schou; Signe Gade Hellmuth; Sandra Elkjær Stallknecht; Katja Leth-Møller; Maria Iversen; Marianne Bjørnø Banke; Iggiannguaq Juhl Petersen; Sarah Louise Klingenberg; Jesper Krogh; Sebastian Elgaard Ebert; Anne Timm; Jane Lindschou; Christian Gluud
Journal:  BMC Psychiatry       Date:  2017-02-08       Impact factor: 3.630

5.  Translation and cultural adaptation of Glasgow Antipsychotic Side-effects Scale (GASS) in Arabic.

Authors:  Yazed AlRuthia; Hadeel Alkofide; Fahad Dakheel Alosaimi; Hisham Alkadi; Albandari Alnasser; Aliah Aldahash; Arwa Basalamah; Maryam Alarfaj
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

6.  Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance.

Authors:  M Catalina Serna; Jordi Real; Inés Cruz; Leonardo Galván; Elisabet Martin
Journal:  BMC Public Health       Date:  2015-11-26       Impact factor: 3.295

7.  Essential psychiatric medicines: wrong selection, high consumption and social problems.

Authors:  Izabela Fulone; Silvio Barberato-Filho; Michele Félix dos Santos; Carolina de Lima Rossi; Gordon Guyatt; Luciane Cruz Lopes
Journal:  BMC Public Health       Date:  2016-01-20       Impact factor: 3.295

8.  An analysis of antidepressant prescribing trends in England 2015-2019.

Authors:  Hasnain M Lalji; Anita McGrogan; Sarah J Bailey
Journal:  J Affect Disord Rep       Date:  2021-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.